Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
L2 family extended-spectrum class A beta-lactamase
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| I72F | - | enhanced resistance | Escherichia coli, Stenotrophomonas maltophilia | Ceftazidime|Cephalexin|AztreonamCephalexin|Cefazolin|Cefoxitin|Ceftazidime|Ceftriaxone|Cefepime|Aztreonam|Meropenem|Imipenem | Reslit | Candidate |
| F72I | - | reduced resistance | Escherichia coli, Stenotrophomonas maltophilia | Cephalexin|Cefazolin|Cefoxitin|Ceftazidime|Ceftriaxone|Cefepime|Aztreonam|Meropenem|ImipenemCeftazidime|Cephalexin|Aztreonam | Reslit | Candidate |
Induction of L1 and L2 beta-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator.
Sec- and Tat-Dependent Translocation of beta-Lactamases across the Escherichia coli Inner Membrane
Metallo-beta-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.
This review discusses the role of metallo-beta-lactamases (MBLs) in multidrug resistance, focusing on their structure, mechanism, and contribution to resistance against β-lactam antibiotics. It highlights the importance of MBLs in the spread of resistance and the challenges they pose for inhibitor design.
Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC's Emerging Infections Program, United States, 2016-2018.
Genomic Characterization of Carbapenem-Resistant Bacteria from Beef Cattle Feedlots.
The study identified several intrinsic carbapenem resistance genes, including blaOXA-50, blaOXA-265, blaOXA-648, blaOXA-278, blaL1, blaL2, and blaPST-2, in carbapenem-resistant bacteria from beef cattle feedlots.
Multidrug-resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat.
The study identifies blaL1 and blaL2 beta-lactamase genes, eptA1 and eptA2 phosphoethanolamine transferases, and other resistance mechanisms in multidrug-resistant Stenotrophomonas maltophilia isolates from residential aged care facilities.
Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.
The study identified several antimicrobial resistance genes in Stenotrophomonas maltophilia, including aac(6')-Iak, aph(3')-IIc, aph(6), bla L1, and bla L2, which contribute to resistance against various antibiotics such as trimethoprim/sulfamethoxazole, minocycline, levofloxacin, and ceftazidime.
The continued evolution of the L2 cephalosporinase in Stenotrophomonas maltophilia: a key driver of beta-lactam resistance.
The study identifies and characterizes L2 beta-lactamase variants in Stenotrophomonas maltophilia, highlighting the role of Phe72 in enzymatic activity and resistance to beta-lactam antibiotics, particularly ceftazidime.
Stenotrophomonas maltophilia of clinical origin display higher temperature tolerance comparing with environmental isolates.
The study identifies several AMR genes in clinical and environmental Stenotrophomonas maltophilia isolates, including beta-lactamases (bla L1, bla L2), aminoglycoside resistance genes (aph(9), aph(3), aph(6)), and a quinolone resistance gene (smqnr). Clinical isolates showed higher prevalence of these genes compared to environmental isolates.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research